Skip to main content

Investigation and Management of Malignant Anal-Canal Tumours

  • Chapter
Progress in Colorectal Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spratt JS. Cancer of the anus. J Surgical Oncol. 2000;74:173–174.

    CAS  Google Scholar 

  2. Rickert RR, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 2000;124:21–25.

    PubMed  CAS  Google Scholar 

  3. Thompson-Fawcett MW, Mortensen NJ McC. Anal transitional zone and columnar cuff in restorative proctocolectomy. Br J Surg. 1996;83:1047–1055.

    Article  PubMed  CAS  Google Scholar 

  4. Fenger C. The anal transitional zone. Acta Pathol Microbiol Scand. 1979;87:379–386.

    Google Scholar 

  5. Shun Wong C, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1999;45: 309–314.

    Google Scholar 

  6. Gordon PH, Nivatvongs S, eds. Principles and Practice of Surgery of the Colon, Rectum, and Anus. St. Louis, MO: Quality Medical Publishing, Inc, 1992:412.

    Google Scholar 

  7. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg. 1976;184:422–428.

    PubMed  CAS  Google Scholar 

  8. Singh R, Nime F, Mittleman A. Malignant epithelial tumors of the anal canal. Cancer 1981;48: 411–415.

    PubMed  CAS  Google Scholar 

  9. Greenall MJ, Quan SHQ, Stearns MW, Urmacher C, DeCosse JJ. Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results. Am J Surg. 1985;149:95–101.

    PubMed  CAS  Google Scholar 

  10. Stearns MW Jr, Quan SHQ. Epidermoid carcinoma of the anorectum. Surg Gynecol Obstet. 1970; 131:953–957.

    PubMed  Google Scholar 

  11. Frisch M, Olsen JH, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer. N Engl J Med. 1994;331:300–307.

    Article  PubMed  CAS  Google Scholar 

  12. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer. 2000;83: 89–90.

    PubMed  CAS  Google Scholar 

  13. Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol. 2000;27:471–479.

    PubMed  CAS  Google Scholar 

  14. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted disease, and the incidence of anal cancer. N Engl J Med. 1987;317:973–977.

    Article  PubMed  CAS  Google Scholar 

  15. Palefsky J, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr. 1998;17:314–319.

    CAS  Google Scholar 

  16. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;342: 792–800.

    PubMed  CAS  Google Scholar 

  17. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen’s disease and anal intraepithelial neoplasia: Review of the literature. Dis Colon Rectum. 1999;42:945–951.

    Article  PubMed  CAS  Google Scholar 

  18. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol. 2000; 27:390–401.

    PubMed  CAS  Google Scholar 

  19. Melbye M, Frisch M. The role of human papillomaviruses in anogenital cancers. Semin Cancer Biol. 1998;8:307–313.

    PubMed  CAS  Google Scholar 

  20. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999; 37:3316–3322.

    PubMed  CAS  Google Scholar 

  21. Scholefield JH. Anal intraepithelial neoplasia. Br J Surg. 1999;86:1363–1364.

    PubMed  CAS  Google Scholar 

  22. Moscicki A-B, Hills NK, Shiboski S, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev. 1999;8:173–178.

    PubMed  CAS  Google Scholar 

  23. Stephenson J. Health agencies update: anal cancer screening. JAMA. 2000;283:3060.

    Google Scholar 

  24. Frisch M, Glimelius B, Wohlfahrt J, Adami H-O, Melbye M. Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst. 1999;91:708–715.

    PubMed  CAS  Google Scholar 

  25. Magdeburg B, Fried M, Meyenberger C. Endoscopic ultrasonography in the diagnosis, staging and follow-up of anal carcinomas. Endoscopy 1999;31:359–364.

    Article  PubMed  CAS  Google Scholar 

  26. Maier AG, Kreuzer SH, Herbst F, et al. Transrectal sonography of anal sphincter infiltration in lower rectal carcinoma. Am J Roentgenol. 2000;175:735–739.

    CAS  Google Scholar 

  27. Wasvary HJ, Barkel DC, Klein SN. Is total colonic evaluation for anal cancer necessary? Am Surg. 2000;66:592–594.

    PubMed  CAS  Google Scholar 

  28. Jass JR, Sobin LH. Histologic Typing of IntestinalTtumours: World Health Organization. 2nd ed. New York, NY: Springer-Verlag; 1989:41–47.

    Google Scholar 

  29. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686–1693.

    Article  PubMed  CAS  Google Scholar 

  30. Staib L, Gottwald T, Lehnert T, et al. Sphincter-saving treatment in epidermoid anal cancer: cooperative analysis of 142 patients in five German university surgical centers. Int J Colorectal Dis. 2000;15: 282–290.

    PubMed  CAS  Google Scholar 

  31. Rich TA. Infusional chemoradiation of rectal and anal cancer. Oncology 1999;13:131–134.

    PubMed  CAS  Google Scholar 

  32. Cummings BJ. The role of radiation therapy with 5-fluorouracil in anal canal cancer. Semin Radiat Oncol. 1997;7:306–312.

    PubMed  Google Scholar 

  33. Corman ML, Haggitt RC. Carcinoma of the anal canal. Surg Gynecol Obstet. 1977;145:674.

    PubMed  CAS  Google Scholar 

  34. Longo WE, Vernova AM, Wad TP. Recurrent squamous cell carcinoma of the anal canal: predicators of initial treatment failure and results of salvage therapy. Ann Surg. 1994;220:40–49.

    PubMed  CAS  Google Scholar 

  35. Nigro ND, Vaitkevicuis VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354–356.

    PubMed  CAS  Google Scholar 

  36. Enker WE, Heilwell M, Janov AJ. Improved survival in epidermoid carcinoma of the anus in association with preoperative multidisciplinary therapy. Arch Surg. 1986;121:1386.

    PubMed  CAS  Google Scholar 

  37. UKCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluourouracil, and mitomycin. Lancet 1996;348:1049–1054.

    Google Scholar 

  38. Flam M, John M, Pajak TF, et al. Role of mitomycin in combinaton with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527–2539.

    PubMed  CAS  Google Scholar 

  39. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–2049.

    PubMed  CAS  Google Scholar 

  40. Allal AS, Obradovic M, Laurencet F, et al. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy. Cancer 1999;85:26–31.

    Article  PubMed  CAS  Google Scholar 

  41. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum. 1998;41:1488–1493.

    PubMed  CAS  Google Scholar 

  42. Hu K, Minsky BD, Cohen AM, et al. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combinedmodality therapy. J Surg Oncol. 1999;70:71–77.

    Article  PubMed  CAS  Google Scholar 

  43. Tyring S. Immune response modification: imiquimod. Aust J Dermatol. 1998;39:S11–S13.

    Google Scholar 

  44. Cummings BJ, Keane TJ, O’sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin-C. Int J Radiat Oncol Biol Phys. 1993;21: 1115–1125.

    Google Scholar 

  45. Volberding P. Looking behind: time for anal cancer screening. Am J Med. 2000;108:674–675.

    Article  PubMed  CAS  Google Scholar 

  46. Brown SR, Skinner P, Tidy J, Smith JH, Sharp F, Hosie KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen’s disease). Br J Surg. 1999;86:1063–1066.

    PubMed  CAS  Google Scholar 

  47. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Treatment options for perianal Bowen’s disease: survey of American Society of Colon and Rectal Surgeons members. Am Surg. 2000;68:686–688.

    Google Scholar 

  48. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137:319–324.

    PubMed  CAS  Google Scholar 

  49. Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum. 2000;43:499–502.

    Article  PubMed  CAS  Google Scholar 

  50. Goldie SJ, Kuntz KM, Weinstien MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999;281:1822–1829.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag London Limited

About this chapter

Cite this chapter

Mahmoud, N.N., Madoff, R.D. (2005). Investigation and Management of Malignant Anal-Canal Tumours. In: Beynon, J., Carr, N.D. (eds) Progress in Colorectal Surgery. Springer, London. https://doi.org/10.1007/1-84628-058-3_6

Download citation

  • DOI: https://doi.org/10.1007/1-84628-058-3_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-823-7

  • Online ISBN: 978-1-84628-058-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics